Halozyme Therapeutics Inc. buy Morgan Stanley
Start price
20.10.25
/
50%
€57.80
Target price
20.10.26
€67.75
Performance (%)
-1.52%
Price
16:57
€56.92
Summary
This prediction is currently active. With a performance of -1.52%, the BUY prediction by Morgan_Stanley is trending in the wrong direction. This prediction currently runs until 20.10.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Halozyme Therapeutics Inc. | -2.637% |
| iShares Core DAX® | -0.298% |
| iShares Nasdaq 100 | 3.125% |
| iShares Nikkei 225® | 1.935% |
| iShares S&P 500 | 1.920% |
Comments by Morgan_Stanley for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (NASDAQ:HALO) had its price target lowered by analysts at Morgan Stanley from $80.00 to $79.00. They now have an "overweight" rating on the stock.
Ratings data for HALO provided by MarketBeat
Stopped prediction by Morgan_Stanley for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€58.38
18.08.25
18.08.25
€68.36
18.08.26
18.08.26
-2.50%
16:57
16:57
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€54.00
06.08.25
06.08.25
€64.83
06.08.26
06.08.26
5.41%
16:57
16:57
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.79
07.08.24
07.08.24
€58.59
07.08.25
07.08.25
6.69%
08.08.25
08.08.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€34.03
26.12.23
26.12.23
€53.50
26.12.24
26.12.24
34.94%
27.12.24
27.12.24
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€40.11
10.08.23
10.08.23
€55.35
10.08.24
10.08.24
26.55%
11.08.24
11.08.24
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€42.50
06.03.23
06.03.23
€60.06
06.03.24
06.03.24
-10.61%
07.03.24
07.03.24